Our People

Dr Lise Lafferty

Research Fellow (co-appointment)
Centre for Social Research in Health

Contact

Fields: Social Change, Public Health and Health Services not elsewhere classified, Aboriginal and Torres Strait Islander Health
Tags: Aboriginal and Torres Strait Islander Health - Health Status and Outcomes, Correctional services, Other social development and community services

Lise recently completed her PhD, titled, “Relationships Matter: Social capital theory and hepatitis C treatment uptake among men in prison. Lise was a recipient of a National Health & Medical Research Council (NHMRC) Aboriginal and/or Torres Strait Islander Health Research Postgraduate Scholarship while undertaking her PhD research. She is currently co-appointed working at the Centre for Social Research in Health on a number of studies pertaining to people living with BBVs, people who inject drugs, and people in prison and in the community and at the Kirby Institute on a study promoting point-of-care sexual health testing in Aboriginal communities.

Lise’ research interests include prisoner health and wellbeing, Aboriginal health and wellbeing, blood-borne viruses, and social justice. She has a community background working with diverse disadvantaged communities including people with disabilities, young people at risk of entering the criminal justice system, and Aboriginal communities.

Publications

    Journal articles

    • Lafferty L;Rance J;Grebely J;Lloyd AR;Dore GJ;Treloar C, 2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, http://dx.doi.org/10.1111/jvh.12987
    • Lafferty L;Chambers GM;Guthrie J;Butler T;Treloar C, 2018, 'Measuring Social Capital in the Prison Setting: Lessons Learned From the Inmate Social Capital Questionnaire', Journal of Correctional Health Care, vol. 24, pp. 407 - 417, http://dx.doi.org/10.1177/1078345818793141
    • Lafferty L;Wild TC;Rance J;Treloar C, 2018, 'A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons', Harm Reduction Journal, vol. 15, http://dx.doi.org/10.1186/s12954-018-0246-6
    • Lafferty L;Rance J;Treloar C, 2018, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, http://dx.doi.org/10.1080/09687637.2018.1494135
    • hilferty F;Lafferty L;valentine K;Cale J;Zmudski F, 2018, 'Changes to home detention in South Australia: Evaluation design and early implementation findings', Advancing Corrections
    • Lafferty L;Rance J;Treloar C, 2018, 'Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting', Drug and Alcohol Dependence, vol. 183, pp. 96 - 101, http://dx.doi.org/10.1016/j.drugalcdep.2017.10.030
    • Lafferty L;Treloar C;van Breda N;Steele M;Hiley S;Flaherty I;Salmon A, 2017, '‘It's Fast, It's Quick, It Stops Me Being Sick’: How to influence preparation of opioid tablets for injection', Drug and Alcohol Review, vol. 36, pp. 651 - 657, http://dx.doi.org/10.1111/dar.12562
    • Lafferty L;Treloar C;Guthrie J;Chambers GM;Butler T, 2017, 'Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison', Journal of Viral Hepatitis, vol. 24, pp. 111 - 116, http://dx.doi.org/10.1111/jvh.12627
    • Lafferty L;Treloar C;Chambers GM;Butler T;Guthrie J, 2016, 'Contextualising the social capital of Australian Aboriginal and non-Aboriginal men in prison', Social Science and Medicine, vol. 167, pp. 29 - 36, http://dx.doi.org/10.1016/j.socscimed.2016.08.040
    • Lafferty L;Treloar C;Butler T;Guthrie J;Chambers GM, 2016, 'Unlocking dimensions of social capital in the prison setting', Health and Justice, vol. 4, http://dx.doi.org/10.1186/s40352-016-0040-z
    • Lafferty L;Chambers GM;Guthrie J;Butler T, 2015, 'Indicators of social capital in prison: a systematic review', Health & Justice, vol. 3, pp. 3 - 7, http://dx.doi.org/10.1186/s40352-015-0020-8

    Reports

    • Bryant J;Rance J;Lafferty L;Treloar C, 2018, Annual Report of Trends in Behaviour 2018: Viral Hepatitis in Australia, Centre for Social Research in Health, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5b57e6eb42bb9
    • Delaney MT;Hill T;Lafferty L;valentine K;Fotheringham M, 2018, Evaluation of the Wesley's Team Casework Model for SHS Services, Social Policy Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.4225/53/5aea5a1235f16
    • Cale J;Hilferty F;Lafferty L;Zmudzki F;valentine K, 2018, Evaluation of SA Home Detention: research report 1 (baseline analysis), Social Policy Research Centre, UNSW Sydney, Sydney, SPRC Report 21/17, http://dx.doi.org/10.4225/53/5a7a750ec5754
    • Bryant J;Rance J;Lafferty L;Treloar C, 2017, Annual Report of Trends in Behaviour 2017: Viral Hepatitis in Australia, Centre for Social Research in Health, UNSW Sydney, Sydney, http://dx.doi.org/10.4225/53/597ea9dc4fef2
    • Simpson PL;Butler T;Dodson M;Levy M;Kaldor J;Allsop S;Gray D;Wilhelm K;Al-Yaman F;Doyle M;Lafferty L, 2017, The Indigenous Offender Health Research Capacity Building Group Community Report, Kirby Institute, University of New South Wales, National Centre for Indigenous Studies, Australian National University, Winnunga Nimmityjah Aboriginal Health Service, National Drug Research Institute,, Sydney

    Conference Posters

    • Rance JA;Lafferty L;Treloar C, 2017, '“Behind closed doors, no one sees, no one knows”: Stigma and treatment as prevention in prison', in “Behind closed doors, no one sees, no one knows”: Stigma and treatment as prevention in prison, Australasian Viral Hepatitis Elimination Conference, Cairns, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, 10 - 11 August 2017
    • Lafferty LM;Rance J;Treloar C, 2017, 'Treatment as prevention in the prison setting: Prisoners’ perspectives', in Treatment as prevention in the prison setting: Prisoners’ perspectives, Australasian Viral Hepatitis Elimination Conference, presented at Australasian Viral Hepatitis Elimination Conference, 10 - 11 August 2017
    • Lafferty LM;Rance J;Treloar C, 2017, 'Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia’s current policy frameworks.', in Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia’s current policy frameworks., Australasian Viral Hepatitis Elimination Conference, Cairns, Queensland, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, Queensland, 10 - 11 August 2017
    • Lafferty LM;Rance J;Treloar C, 2017, 'Does Australia’s policy landscape support HCV treatment as prevention in the prison setting in the new DAA era?', in Does Australia’s policy landscape support HCV treatment as prevention in the prison setting in the new DAA era?, 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 - 08 September 2017
    • Lafferty LM;Treloar C;Chambers GM;Butler T;Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', in Identifying the social capital of men in prison screening positive for HCV, 4th International Symposium on Hepatitis Care in Substance Users, Sydney, Australia, presented at 4th International Symposium on Hepatitis Care in Substance Users, Sydney, Australia, 07 - 09 October 2015
    • Lafferty LM;Treloar C;Chambers GM;Butler T;Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', in Identifying the social capital of men in prison screening positive for HCV, HEP DART 2015, Hawaii, USA, presented at HEP DART 2015, Hawaii, USA, 06 - 10 December 2015

    Theses / Dissertations

    Conference Presentations

    • Lafferty LM;Rance J;Treloar C, 2017, 'Prisoners' perspectives of treatment as prevention for hepatitis C in the prison setting', presented at HEP DART, Hawaii, USA, 03 - 07 December 2017
    • Lafferty LM;Rance J;Treloar C, 2017, 'Treatment as Prevention in the Prison Setting: Prisoners' Perspectives', presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 - 08 September 2017
    • Lafferty LM;Treloar C;Chambers GM;Butler T;Guthrie J, 2016, 'Exploring dimensions of social capital of men in prison living with hepatitis C', presented at Social Research Conference on HIV, Viral Hepatitis and Related Diseases, 31 March - 01 April 2016
    • Lafferty LM;Treloar C;Butler T, 2016, 'Building social capital to promote HCV treatment in prison', presented at National Hepatitis Health Promotion Conference, Melbourne, Australia, 19 - 20 May 2016
    • Lafferty LM;Treloar C;Guthrie J;Chambers GM;Butler T, 2016, 'Utilising social capital to promote HCV treatment in prison', presented at 5th International Symposium on Hepatitis Care in Substance Users (INHSU), Oslo, Norway, 07 - 09 September 2016
    • Lafferty LM;Treloar C;Guthrie J;Chambers GM;Butler T, 2016, 'Relationships Matter: Social capital theory and the delivery of hepatitis C treatment in prison', presented at 10th Australasian Viral Hepatitis Conference, Gold Coast, Australia, 29 September - 01 October 2016
    • Lafferty LM;Treloar C;Steele M;van Breda N;Hiley S;Salmon A, 2016, 'Preparing Prescription Opiates for Injection: Understanding Preferences and Practices', presented at Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Sydney, Australia, 30 October - 02 November 2016
    • Lafferty LM;Guthrie J;Chambers GM;Butler T, 2015, 'Social capital of men in prison living with hepatitis C', presented at 2nd National Complex Needs Conference, 17 - 18 November 2015
    • Lafferty LM;Guthrie J;Chambers GM;Butler T, 2013, 'Determining social capital indicators for accessing treatment and changes in QALYs post-treatment: HCV treatment among inmates in NSW', presented at National Indigenous Health Conference, Cairns, Australia, 25 - 27 November 2013
    • Lafferty LM, 2013, 'Determining social capital indicators for accessing treatment and changes in QALYs post-treatment: HCV treatment among inmates in NSW', presented at National Indigenous Health Conference, Cairns, Australia, 25 - 27 November 2013

Related news